Skip to content
CancerIndex

Loading the knowledge graph…

DEFENDOR: A Multicenter Prospective Observational Post-registration stuDy of Extimia® (INN: empEgfilrastim) to Evaluate Efficacy and saFEty in patieNts With soliD tumORs — knowledge graph · CancerIndex